Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Targeting Endoplasmic Reticulum Stress to Correct Vascular Insulin Resistance and Glycemic Dysregulation

NCT03331432 is registered in ClinicalTrials.gov with University of Missouri-Columbia as lead sponsor.

NCT NCT03331432
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03331432 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Targeting Endoplasmic Reticulum Stress to Correct Vascular Insulin Resistance and Glycemic Dysregulation
Lead sponsor
University of Missouri-Columbia
Phase
Not applicable
Overall status
Completed
Start date
October 28, 2015
Completion date
February 14, 2018
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes mellitus